Elsevier

Human Pathology

Volume 24, Issue 6, June 1993, Pages 602-607
Human Pathology

Original contribution
Isolated atrial amyloidosis: A clinicopathologic study indicating increased prevalence in chronic heart disease

https://doi.org/10.1016/0046-8177(93)90239-DGet rights and content

Abstract

Congo red screening of 211 consecutive cardiac biopsy specimens obtained during cardiac surgery from 167 patients revealed 26 (16%) instances of isolated atrial amyloidosis (IAA). The ages of IAA-positive patients ranged from 25 to 52 years (mean age, 39 years). Twenty-three (88%) IAA-positive biopsy specimens were from patients with chronic rheumatic heart disease (CRHD) while three (12%) were from patients with an atrial septal defect (ASD). The prevalence of IAA in the CRHD patients was 23%, appreciably higher than that in the ASD patients (15%) and in other patients with atrial biopsies. The prevalence of IAA in both CRHD and ASD patients was significantly higher (P < .001) than in controls. Controls consisted of 247 healthy adults who were autopsied after traumatic deaths, with an age range of 18 to 89 years (mean age, 38 years). Only seven (3%) control subjects were IAA positive; all were over 40 years of age. Isolated atrial amyloidosis deposits were permanganate resistant and immunohistochemically positive for human amyloid P (AP) protein and negative for human amyloid-associated (AA) protein and immunoglobulin light chains. They were observed as fine congophilic and birefringent deposits in intramyocardial vessel walls, along the myocardial sarcolemma, and in the subendocardium. There was associated myocyte hypertrophy but no atrophy. Electron microscopy demonstrated typical nonbranching amyloid fibrils. It is postulated that stretching of the atria in chronic heart disease results in a raised prevalence of IAA. Recent reports that IAA contains atrial natriuretic peptide, a polypeptide hormone product of atrial myocytes, supports this view.

References (17)

There are more references available in the full text version of this article.

Cited by (40)

  • Molecular imaging of atrial myopathy: Towards early AF detection and non-invasive disease management

    2022, Trends in Cardiovascular Medicine
    Citation Excerpt :

    Additional targets would be worthy of investigation. For instance, accumulation of insoluble, misfolded proteins could be of considerable interest, since isolated atrial amyloidosis (IAA; classified as atrial cardiomyopathy type IVa), attributed to structural heart diseases, such as rheumatic heart disease (RHD) and atrial septal defects [109], is characterized by focal atrial buildup of extracellular proteinaceous deposits. Furthermore, based on neuropathological evidence that amyloid Aβ40 and Aβ42 proteins are deposited in the cerebral vasculature during cerebral amyloid angiopathy (CAA) [110], molecular imaging of cerebrospinal fluid Aβ40 that accumulates in the heart specifically in AF [111] would provide better management criteria for those AF patients with CAA.

  • Cardiac amyloidosis: An underdiagnosed/underappreciated disease

    2019, European Journal of Internal Medicine
    Citation Excerpt :

    Despite the presence of LVH, the ECG may show low-voltage QRS complexes in variable percentages (~45% in AL CM, ~30% in ATTRwt and 16–45% in ATTRm) [53]; pseudo-infarction pattern with poor R-wave progression and/or pathologic Q waves may be seen in ~two-thirds of cases, and AF in ~one-third of patients [18,65]. As mentioned, atrial amyloidosis probably related to atrial natriuretic peptide amyloid fibril deposits has been reported as a frequent histological finding as detected in atrial appendage specimens obtained from patients with AF and rheumatic or other cardiac diseases [66–68]. Echocardiography is the principal diagnostic tool for cardiac amyloidosis [69].

  • EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication

    2017, Heart Rhythm
    Citation Excerpt :

    Isolated atrial amyloidosis is also linked to structural heart disease. In atrial biopsies from 167 patients undergoing cardiac surgery, 23 of 26 amyloid-positive specimens were from patients with rheumatic heart disease (RHD), while the remaining 3 came from patients with atrial septal defects.80 The overall incidence of 16% was greater than that was seen in control atrial autopsy specimens from trauma victims (3%).

  • EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication

    2016, Journal of Arrhythmia
    Citation Excerpt :

    The PV atrial reversal velocity has also been used as a measurement of LA function [317,377,379–382]. In the presence of reduced LV compliance and elevated filling pressures, atrial contraction results in significant flow reversal into the PVs [80,81]. Studies have also demonstrated that Doppler tissue imaging can be used as an accurate marker of atrial function [383,384].

  • Age-related Cardiovascular Changes and Diseases

    2016, Cardiovascular Pathology: Fourth Edition
View all citing articles on Scopus
View full text